Voglibose administration regulates body weight and energy intake in high fat-induced obese mice
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Do, Hyun Ju | - |
dc.contributor.author | Jin, Taeon | - |
dc.contributor.author | Chung, Ji Hyung | - |
dc.contributor.author | Hwang, Ji Won | - |
dc.contributor.author | Shin, Min-Jeong | - |
dc.date.accessioned | 2021-09-05T12:16:31Z | - |
dc.date.available | 2021-09-05T12:16:31Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-01-17 | - |
dc.identifier.issn | 0006-291X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/99526 | - |
dc.description.abstract | We tested whether long-term administration of voglibose (VO) prevents diet induced obesity in addition to hypoglycemic effects in high fat fed mice and further investigated the underlying mechanisms by which voglibose exerts its weight lowering effect. Male C57BL/6 mice were fed ad libitum for 12 weeks with the control diet (CTL), high-fat diet (HFD) or the HFD with VO supplementations. Blood lipid profile, plasma leptin levels and hepatic triglyceride content, as well as expressions of genes involved in appetite and mitochondrial function were examined. The results showed that VO significantly reduced body weight, fat mass and energy intakes in high fat fed mice. VO showed improved metabolic profiles including blood glucose, triglyceride and free fatty acid. Elevated levels of plasma leptin in HFD were significantly reduced with the VO, furthermore, VO modulated the hypothalamic expressions of leptin receptors and appetite related genes. VU showed the upregulated expressions of PGC-1 in the liver and epididymal adipose tissue. In conclusion, VO may exert antiobesity properties through reductions in energy intake and improvement in mitochondrial function, indicating that VO has potential therapeutic use in patients with obesity, type 2 diabetes, and related complications. (C) 2013 Elsevier Inc. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
dc.subject | ALPHA-GLUCOSIDASE INHIBITORS | - |
dc.subject | GLUCAGON-LIKE PEPTIDE-1 | - |
dc.subject | TYPE-2 DIABETES-MELLITUS | - |
dc.subject | DIET-INDUCED OBESITY | - |
dc.subject | INSULIN-RESISTANCE | - |
dc.subject | LEPTIN RESISTANCE | - |
dc.subject | PLASMA-GLUCOSE | - |
dc.subject | NIDDM PATIENTS | - |
dc.subject | SECRETION | - |
dc.subject | SENSITIVITY | - |
dc.title | Voglibose administration regulates body weight and energy intake in high fat-induced obese mice | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Shin, Min-Jeong | - |
dc.identifier.doi | 10.1016/j.bbrc.2013.12.120 | - |
dc.identifier.scopusid | 2-s2.0-84893638847 | - |
dc.identifier.wosid | 000331415000054 | - |
dc.identifier.bibliographicCitation | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, v.443, no.3, pp.1110 - 1117 | - |
dc.relation.isPartOf | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | - |
dc.citation.title | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | - |
dc.citation.volume | 443 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 1110 | - |
dc.citation.endPage | 1117 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Biophysics | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biophysics | - |
dc.subject.keywordPlus | ALPHA-GLUCOSIDASE INHIBITORS | - |
dc.subject.keywordPlus | GLUCAGON-LIKE PEPTIDE-1 | - |
dc.subject.keywordPlus | TYPE-2 DIABETES-MELLITUS | - |
dc.subject.keywordPlus | DIET-INDUCED OBESITY | - |
dc.subject.keywordPlus | INSULIN-RESISTANCE | - |
dc.subject.keywordPlus | LEPTIN RESISTANCE | - |
dc.subject.keywordPlus | PLASMA-GLUCOSE | - |
dc.subject.keywordPlus | NIDDM PATIENTS | - |
dc.subject.keywordPlus | SECRETION | - |
dc.subject.keywordPlus | SENSITIVITY | - |
dc.subject.keywordAuthor | Voglibose | - |
dc.subject.keywordAuthor | Obesity | - |
dc.subject.keywordAuthor | Appetite | - |
dc.subject.keywordAuthor | Leptin | - |
dc.subject.keywordAuthor | Leptin receptor | - |
dc.subject.keywordAuthor | Mitochondria | - |
dc.subject.keywordAuthor | PGC1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.